Moderna INC is the US based biotechnology company whose vaccine was first to undergo human trials in United states. Moderna vaccine lead to creation of strong antibodies in 8 human test subjects and worked on all of them effectively giving ray of hope to billions of people.
It's share rose by approx 20% in NYSE after successful initial findings. Moderna's news worked as booster for other stock exchanges as well considering the global cure.
Pharma companies "Pfizer", " Johnson &Johnson", "Sanofi", " Glaxosmithcline(GSK) "e.t.c. are also more or less at same level of results. So, we as consumer can expect competitive price benefits. Investors are having good opportunities in these stocks as the scale of infection is so huge that demand of vaccines will require supply from many companies.